Results were in line with expectations as per previous call. Seq revenue is up 10% and EBIDTA is up from 13.7% to 15.8%. Q3 Con call will give more details on composition, outlook and any development.
Posts in category Value Pickr
Oriental Carbon and Chemicals Ltd (10-02-2024)
The mgmt attributed decline in earnings and revenue to dumping by the Chinese.
However, earlier it has always been stated that the product approval nd finalising purchase by the clients is a long drawn process which is not easy to obtain.
If that’s the casr, thn how come Chinese dumping happen all of a sudden. Definitely a red flag for me, bt probably other long term investors can shed sm light.
Discloure :- Invested
Parameters to check before buying a stock (10-02-2024)
Regarding promoter holding, reasonable holding indicates confidence by the promoters in their company. There could be exceptions though. Dividend being paid regularly indicates good intent of the management towards the share holders.
Parameters to check before buying a stock (10-02-2024)
Yes. You can compare with the long term median PE.
Annapurna Swadisht Ltd – A Swadisht FMCG investment? (10-02-2024)
Hi Guys,
What does it meant by this paragraph on page 11. Is it saying that volumes are low in North East Region. So profit will be low in upcoming results?
https://nsearchives.nseindia.com/corporate/ANNAPURNA_10022024123443_Intimation_SE_PB_ASL.pdf
Rategain – Fast Growing SaaS Leader (10-02-2024)
RateGain’s Bhanu Chopra: Man With Rs 127 Cr House, Rs 100 Bn Firm | Rollin’ With The Boss Ep 05
Here’s a very casual interview of Bhanu Chopra in which he reflects about his company (Rategain) and life in general. In this he aspires to make Rategain a $1B revenue generating company.
Iris Business Services – Emerging SAAS Microcap (10-02-2024)
The results are pretty good:
- Sales grew 14% QoQ and 45% YoY
- EBITDA grew 24% QoQ and 16% YoY. Reason for lower EBITDA growth is that company has recently increased its partnerships in US and LATAM as a result of which partnership fees has 2x QoQ and 6x YoY. Also, travelling costs have increased which is a good indicator for their potential SAAS product marketing in US.
- Segment-wise revenue growth and contribution is as below
| Sales | Q3 FY24 | Contribution (%) | Q2 FY 24 | Contribution (%) | QoQ | Q3 FY 23 | Contribution (%) | YoY | |
|---|---|---|---|---|---|---|---|---|---|
| Regulators | Collect | 12.52 | 46% | 10.8 | 45% | 15.82% | 6 | 30% | 120.42% |
| Filers | Create | 13.65 | 50% | 12.3 | 52% | 10.62% | 12.28 | 65% | 11.16% |
| GST, Analytics | Consume | 1.16 | 4% | 0.8 | 3% | 45.00% | 0.91 | 5% | 27.47% |
- With regards to segment-wise revenue, Collect has been the driver which is a low growth RFP-driven segment where company already holds 10% of world’s XBRL market share.
- However, keep in mind that the major potential growth driver, which is the Create segment is based on SAAS model where billing typically happens at the end of financial year. So, the 11% YoY growth in this segment is not a good indicator
- Need to keep a close eye on Create segment growth in Q4 results to assess the full growth trajectory.
- Also, the company has shared Segment results, anyone has any idea what they are? Operating profit?
Will publish a more detailed analysis of this company that has been resting in my drive for a while and I’m too busy to publish.
Discl: Invested
Companies with 20%+ growth guidance for next few years (10-02-2024)
Capacite infra and pennar industries have mentioned in concall about growth >25% for next 3 years.
Orchid Pharma Ltd (10-02-2024)
Land acquisition in Jammu
Jammu to strengthen NPV and financial viability of the 7-ACA project
Apart from the PLI incentives available under Production Linked Incentive (PLI)
Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials
(KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the
Country, the Jammu location provides additional meaningful benefits to ORCP 1)
Power is a key component of the total cost of manufacturing 7-ACA, and Jammu has
the lowest power cost in the country, 2) under the New Central Sector Scheme for
Industrial Development of Union Territory of Jammu & Kashmir, ORCHP will be
eligible for GST refund at 18% 3) Cumulative PLI incentive of Rs. 6bn
Can Someone Please Guide Newbie’s Like Me (10-02-2024)
It is basic accounting 101. It is the accounting equation.
Assets = Liabilities + Equity